Affective Care

Affective Care in New York City, led by founder Dr. Kyle Lapidus, offers ketamine treatments using multiple administration methods along with BrainsWay Deep TMS for major depression and other mood disturbances, OCD, PTSD, and general anxiety. Dr. Lapidus is a Harvard-trained, board-certified psychiatrist who earned his MD and PhD at Albert Einstein College of Medicine and conducted pioneering research on ketamine, including intranasal administration, at Mount Sinai.

The practice draws on cutting-edge research across psychiatry, psychology, and cognition to treat the most difficult and treatment-resistant cases. Ketamine works as a glutamate NMDA receptor antagonist to provide rapid antidepressant benefits and increase synaptic connections.

Alongside interventional treatments, Affective Care offers complete assessments, psychopharmacology including off-label options, psychotherapy, neuromodulation, and Suboxone treatment.